Why work with us?

Doherty Clinical Trials can execute early phase healthy volunteer studies, but we are also ready and keen to deliver tailored solutions for clients who would value input into study design and development. Specialised studies offer unique opportunities to accelerate decision making, reduce costs and substantially decrease timelines for clinical development.

Key differentiators for our services are:

  • Our enthusiasm and ability to provide bespoke solutions, with input for all stages of trial design and execution available from our team and broad networks of world-leading clinicians and scientists
  • Ethical delivery of high-quality human challenge trials that address cost and time barriers for the development of breakthrough therapeutics and vaccines
  • Use of our Melbourne facility – the only unit in Australia specifically commissioned to deliver human challenge studies

We will be able to deliver a range of human challenge models including malaria, group A streptococcus and respiratory viruses such as influenza.

If you would like to discuss any aspect of your clinical trial needs, contact us. We’re keen to chat with you about potential solutions.

Our services

Our specialised clinical trial solutions are designed to accelerate the development of novel medicines and vaccines for our key partners and industry clients. 

We can work with a range of vendors, partners and collaborating centres to ensure end-to-end clinical trial delivery. At the same time, our clients benefit from the deep clinical and scientific expertise across Melbourne’s Parkville Biomedical Precinct, including at The Peter Doherty Institute for Infection and Immunity, Royal Melbourne Hospital, Murdoch Children’s Research Institute and Walter and Eliza Hall Institute.

Our services include:

  • Full operational delivery of early-phase clinical studies requiring inpatient containment or isolation
  • Access to a range of human challenge models
  • Input on study design, protocol development and comprehensive medical review, including assistance with the Investigator Brochure, prior to ethics submission
  • Assistance with ethics and regulatory submissions
  • Participant recruitment

We can adapt our services to your needs and create bespoke clinical trial solutions. Contact us to discuss your requirements

Our capabilities

We are equipped to accelerate development of new therapies and vaccines for infectious diseases and other therapeutic areas.

Our dedicated facility is Australia’s only unit specifically established to deliver human challenge studies. The purpose-built facility can accommodate challenge models for a range of pathogens including malaria, group A streptococcus and respiratory viruses.

The Melbourne facility contains:

  • 25-bed, purpose-built unit for inpatient clinical research
  • Specialist containment clinical trial facilities for careful supervision of participants
  • Six rooms for isolation of trial participants, for example, during respiratory virus challenge studies
  • Screening and outpatient rooms
  • Dedicated PC2 laboratory
  • Pharmacy and an administrative area

Quality management

Doherty Clinical Trials Ltd is dedicated to accelerating the development of novel medicines and vaccines through innovative early phase and human challenge clinical trials of the highest quality.

Our Quality Management System is in development and will ensure Doherty Clinical Trials Ltd is aligned with all relevant legislation, regulations, research codes of practice, and international clinical trial compliance requirements such as Good Clinical Practice (GCP) quality guidelines.

Quality management is a key foundation in all our activities and is incorporated into our systems, processes and staff training.

Our Team

A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.

Dr Andrew Brockway

Chief Executive Officer

Professor James McCarthy

Chief Medical Officer

Chris Kearney

Senior Program Manager

Sally O'Callaghan

Clinical Operations and Nursing Director

Thu-Anh Pham

Quality and Compliance Director

Dr Julia Marshall

Human Infection Challenge Trial Consultant